Abstract
The Hippo pathway plays critical roles in cell growth, differentiation, organ development, and tissue homeostasis whereas its dysregulation can lead to tumorigenesis. YAP/TAZ are transcription co-activators and represent the main downstream effectors of the Hippo pathway. Here we show that heat stress induces a strong and rapid YAP dephosphorylation and activation. The effect of heat shock on YAP is dominant to other signals known to modulate the Hippo pathway. Heat shock inhibits LATS kinase by promoting HSP90-dependent LATS interaction with and inactivation by PP5 phosphatase. Heat shock also induces LATS ubiquitination and degradation. YAP/TAZ are crucial for cellular heat shock responses, including the heat shock transcriptome and cell viability. This study uncovers previously unknown mechanisms of Hippo regulation by heat shock as well as physiological functions of YAP in heat stress response. Our observations also reveal a potential combinational therapy involving hyperthermia and targeting of the Hippo pathway.
Keywords: Hippo, YAP, LATS, phosphorylation, heat shock, HSP90, cancer
INTRODUCTION
The Hippo pathway, originally discovered in Drosophila, plays an evolutionarily conserved role in the regulation of cell growth, cell fate, organ development, and tissue homoeostasis1, 2. Dysregulation of the Hippo pathway contributes to tumorigenesis3, 4. Core components of the mammalian Hippo pathway consist of a kinase cascade, in which mammalian Ste20-like kinases 1/2 (MST1/2) or mitogen-activated protein kinase kinase kinase kinase family members (MAP4Ks) phosphorylate and activate the large tumor suppressor 1/2 (LATS1/2), and two downstream transcription co-activators, Yes-associated protein (YAP) and WW domain–containing transcription regulator protein 1 (WWTR1; also known as TAZ)5. LATS inhibits YAP and TAZ through direct phosphorylation. Inactivation of the Hippo kinase cascade leads to dephosphorylation, nuclear translocation, and activation of YAP/TAZ, which then induce gene expression mainly through binding to the TEA domain (TEAD) family of transcription factors6, 7.
Heat shock is a common physiological and pathological stress that has been extensively studied. Activation of the heat shock factor (HSF) plays a critical role in the induction of heat shock proteins (HSPs) to protect cells from heat stress8. Hyperthermia is a therapeutic procedure in which cancer is treated by raising temperature in the tumor tissue. In certain cancers, hyperthermia is applied as an adjunct treatment with various established cancer therapy strategies, such as radiotherapy and chemotherapy9. The rationale for hyperthermia is based on the cell-killing effects of high temperature. Hyperthermia can inhibit cancer cell viability by inducing unique gene expressions, inhibiting angiogenesis, and activating immune response10, 11. However, many key questions remain to be answered for hyperthermia therapy. For example, not only are the predictors of cancer sensitivity to hyperthermia unknown, but the signal pathways involved are also poorly understood9.
In the last decade, many signals have been discovered to regulate the Hippo pathway5, 12. Most signals are known to act upstream of MST1/2 and MAP4Ks to control YAP/TAZ activity. In this study, we discovered that heat shock potently induces YAP dephosphorylation and activation. Heat shock inhibits LATS by two mechanisms, rapid dephosphorylation followed by protein degradation, the former of which is likely mediated through HSP90 dependent interaction with PP5. YAP/TAZ play an important role in heat shock response by enhancing the heat shock transcriptome and cell survival.
RESULTS
YAP is activated by heat shock
To identify new signals that may control the Hippo pathway, we tested many stress conditions and found that heat shock induced YAP dephosphorylation (Fig. 1a). Shifting the high density culture, which is known to induce YAP phosphorylation13, of HEK293A and A549 cells to 43°C induced rapid and complete YAP dephosphorylation, as shown by pYAP(S127) phosphorylation and mobility shifts in phos-tag gels. Heat shock also reduced LATS1 protein whereas the levels of MST1/2 and MAP4K4/7 were unaffected (Fig. 1a). Notably, the reduction of LATS protein was slower than YAP dephosphorylation, indicating that LATS might be rapidly inactivated upon heat shock.
The heat shock transcription factor 1 (HSF-1) is a master heat responsive transcription factor and plays a key role in heat stress response 8. Heat shock caused HSF-1 mobility shift (Fig. 1a), consistent with HSF-1 phosphorylation and activation14. Notably, YAP dephosphorylation occurred slightly earlier than HSF-1 phosphorylation, suggesting that YAP dephosphorylation is not due to HSF-1 activation. Heat shock induced YAP dephosphorylation in many cell types, including HCT116, MEL270, NIH3T3, SCC7 and B16-OVA (Extended Data Fig. 1a).
We found that YAP dephosphorylation induced by heat shock was rapidly reversible when cells were shifted to 37°C, though different cell types showed different recovery kinetics (Fig. 1b). Longer exposure to heat shock caused slower recovery, possibly due to the downregulation of LATS protein. Moreover, the heat shock-induced YAP dephosphorylation sustained up to 24 hours (Extended Data Fig. 1b). Mild heat shock at 40°C induced moderate YAP dephosphorylation in A549 cells but not in HEK293A cells (Extended Data Fig. 1c). Cold temperature of 25°C or 4°C did not induce YAP dephosphorylation (Extended Data Fig. 1d).
The LATS-dependent phosphorylation of YAP/TAZ results in 14-3-3 binding and cytoplasmic localization13. As expected, immunofluorescence staining revealed that heat shock induced YAP/TAZ nuclear accumulation (Fig. 1c, d). Consistent with YAP/TAZ activation, heat shock increased the expression of YAP/TAZ target genes CTGF and CYR61 (Fig. 1e).
In addition to high density, we queried whether heat shock could activate YAP under other inhibitory conditions. Surprisingly, heat shock was able to activate YAP under all inhibitory signals tested, including serum starvation, energy stress by 2-deoxyglucose (2DG), cAMP elevation by forskolin and IBMX, F-actin disruption by latrunculin B or cytochalasin D, osmotic stress by sorbitol, and cell detachment (Fig. 1f). These observations demonstrate that heat shock universally induces a rapid and dramatic YAP activation and likely regulates the Hippo pathway at a step proximal to YAP.
Heat shock induces LATS dephosphorylation and degradation
We tested whether heat shock inhibited the Hippo kinase cascade. We found that 15 min of heat shock strongly reduced LATS phosphorylation in the hydrophobic motif (Thr1079 for LATS1) (Fig. 2a), which is an activating phosphorylation by MST or MAP4Ks15, 16. LATS1 protein levels were also decreased although slower than LATS dephosphorylation (Fig. 2b). Notably, LATS1(Thr1079) phosphorylation was still dramatically reduced even when LATS1 protein levels were normalized (Fig. 2a), indicating that heat shock inhibits LATS by two mechanisms, a rapid dephosphorylation and a slower degradation.
To directly ascertain LATS inactivation by heat shock, we measured LATS1 activity using GST-YAP as a substrate. LATS1 immunoprecipitated from heat shocked HEK293A cells exhibited a rapid decrease of kinase activity (Fig. 2c). Moreover, LATS1(Thr1079) phosphorylation was restored quickly after shifting cells to 37°C (Fig. 2d). We conclude that LATS1 phosphorylation and activity are potently and reversibly regulated by heat shock, and likely be responsible for the corresponding changes in YAP phosphorylation. The scaffold protein MOB1 interacts with and facilitates LATS phosphorylation/activation by MST1/216, 17. Co-immunoprecipitation (Co-IP) indicated that heat shock had no effect on MOB1-LATS1 interaction (Fig. 2e, Extended Data Fig. 2d).
Heat shock not only induced dephosphorylation but also reduced protein levels of LATS1 and LATS2 (Fig. 2f). To determine whether proteasome and/or lysosome is responsible for LATS1 degradation, cells were treated with the proteasome inhibitor MG132 or the lysosome inhibitor Bafilomycin A1. We found that LATS1 levels were stabilized by MG132, but not Bafilomycin A1 (Fig. 2g), suggesting that heat shock induces LATS degradation via proteasome. Consistently, heat shock increased LATS1 ubiquitination (Fig. 2h, i). Neither MG132 nor Bafilomycin A1 affected the dephosphorylation of LATS1 and YAP (Fig. 2g), indicating that heat shock induces LATS1 dephosphorylation and degradation via independent mechanisms, and LATS inactivation by dephosphorylation is largely responsible for the reduced YAP phosphorylation.
To further support our model, we examined YAP phosphorylation in LATS1/2 DKO cells. LATS1/2 knockout abolished the vast majority of YAP phosphorylation (Fig. 2j), as predicted by the current dogma that LATS is the major YAP kinase. However, energy starvation by 2-DG or osmotic stress by sorbitol could still induce some YAP phosphorylation in LATS1/2 DKO cells (Fig. 2k), consistent with previous reports that AMPK and NLK could directly phosphorylate YAP under energy starvation and osmotic stress, respectively18-20. However, the LATS independent YAP phosphorylation was largely insensitive to heat shock (Fig. 2k), supporting the notion that heat shock acts through LATS to modulate YAP phosphorylation.
MST and MAP4Ks are not key mediators from heat shock to LATS inactivation
We investigated whether MST1/2 and MAP4Ks are involved in heat shock-induced YAP regulation by comparing HEK293A wild-type (WT), MST1/2 double-knockout (DKO), and MAP4K4/6/7 triple-knockout (TKO) cell lines. Deletion of MAP4K4/6/7 caused a moderate delay in the dephosphorylation of YAP and LATS1 in response to heat stress (Fig. 3a). In contrast, MST1/2 deletion slightly accelerated these effects on both YAP and LATS1. Deletion of MST1/2 or MAP4Ks did not affect LATS1 protein levels (Fig. 3a). In response to heat shock, MAP4K4/6/7 TKO cells showed similar delays in YAP dephosphorylation under high cell density or serum starvation conditions (Extended Data Fig. 2a). Consistently, YAP/TAZ nuclear accumulation by heat shock was slower in the MAP4K4/6/7 TKO cells. However, YAP still translocated into the nucleus when exposed to heat shock for longer durations (Fig. 3b, c). Upon recovery at 37°C following 1 hour of heat shock, YAP re-phosphorylation was moderately delayed in MST1/2 DKO, but not in the MAP4K4/6/7 knockout cells (Fig. 3d). These observations indicate that neither MST1/2 nor MAP4K4/6/7 are absolutely required for heat shock-induced YAP regulation.
We measured kinase activity of MST1 and MAP4K4 and found that heat shock had no detectable effect on either (Fig. 3e). Consistently, heat shock had little effect on the phosphorylation of GST-MST1 (Extended Data Fig. 2b). Intriguingly, heat shock elevated the interaction of LATS-MAP4K4 or LATS-MST1 (Fig. 3f, g). The functional implication of these increased interactions is currently unclear. To further investigate the role of MST1/2 or MAP4Ks, we rescued the MM8KO (MST1/2-MAP4K1/2/3/4/6/7 KO) cells with either MST1 or MAP4K4. The MST1-rescued cells showed a slower YAP dephosphorylation than that of MAP4K4-rescued cells upon heat shock (Extended Data Fig. 2c). Moreover, the MST1-rescued cells recovered faster than the MAP4K4-rescued cells (Fig. 3h). Collectively, our data indicate that MST1 or MAP4K4 unlikely acts as a key mediator relaying heat shock signal to LATS regulation, although they may still phosphorylate LATS1 during the heat shock.
HSP90 is involved in heat shock-induced YAP dephosphorylation
HSF-1, HSP70, and HSP90 play critical roles in heat shock response 21. It has been reported that inhibition of HSP90 by 17-AAG caused YAP dephosphorylation and nuclear localization22, 23. However, both studies were solely based on pharmacological HSP90 inhibition and heat shock response was not examined. To test the roles of these genes in YAP regulation, we generated HEK293A knockout cell lines by CRISPR-Cas9 technology 24. Deletion of HSF-1 completely abolished expression of HSF-1 target genes (Extended Data Fig. 3a). However, the heat shock-induced YAP mobility shifts were not affected by HSF-1 deletion (Fig. 4a). Pretreatment of cells with chemical chaperone 4-PBA or DMSO25 did not block YAP dephosphorylation upon heat shock (Extended Data Fig. 3b).
Deletion of HSP70-1/2 had only a minor delay in YAP dephosphorylation (Fig. 4b), indicating that HSP70 is largely dispensable for YAP regulation by heat shock. HSP90 is essential for cell growth and survival and has two major isoforms HSP90α (encoded by HSP90AA1, inducible) and HSP90β (encoded by HSP90AB1, constitutive)26. We utilized two HSP90α/β partial knockout clones for our experiments. Partial deletion of HSP90α/β compromised the heat shock-induced dephosphorylation of YAP and LATS1 (Fig. 4c, Extended Data Fig. 3c, d). LATS1 degradation was also compromised in HSP90α/β DKO cells (Fig. 4c). Transient knockdown of HSP90α/β by short interfering RNA (siRNA) also largely blocked the heat shock-induced dephosphorylation of YAP and LATS1 (Fig. 4d, e, Extended Data Fig. 3e). Furthermore, HSP90 knockdown delayed LATS inactivation by heat shock whereas HSP90 overexpression had no effect (Fig. 4f).
We observed that heat shock rapidly enhanced the association of the inducible HSP90α with LATS1 (Fig. 4g), especially considering the reduction of LATS protein. In contrast, heat shock had little effect on the interaction of the constitutively expressed HSP90β with LATS1 or MAP4K4 (Fig. 4g). Taken together, HSP90 plays a critical role in heat shock-induced LATS1 degradation and dephosphorylation, the latter is possibly via the heat shock-inducible interaction of HSP90-LATS.
PP5 is involved in LATS dephosphorylation by heat shock
Our data indicate that dephosphorylation appears to be primarily responsible for rapid LATS inactivation by heat shock. Protein phosphatase 5 (PP5) is known to be activated by association with HSPs, including HSP9027, 28. We found that the dephosphorylation of LATS1 and YAP by heat shock was diminished in the PP5 KO cell pools generated by two independent CRISPR sequences (Fig. 5a). Similar results were observed in cells with PP5 knockdown by siRNA (Fig. 5b, c). Treatment with LB-100, which inhibits both PP2A and PP5, also blocked the dephosphorylation of YAP and LATS1 (Fig. 5d). These observations support a role of PP5 in heat shock-induced LATS dephosphorylation.
To test whether PP5 is specifically involved in LATS regulation by heat shock, we examined the effect of LPA, which is known to induce LATS inactivation by acting upstream of MST and MAP4K29, 30, in PP5 deficient cells. YAP dephosphorylation induced by LPA was not affected by PP5 deficiency (Fig. 5e) whereas the effect of heat shock was significantly altered, suggesting a selective role of PP5 in heat shock response. We observed that heat shock increased the interaction of transfected FLAG-PP5 with endogenous LATS1 (Fig. 5f). Similarly, heat shock increased the association between HA-LATS1 and FLAG-PP5 (Fig. 5g). Interestingly, the interaction between LATS1 and PP5 was reduced in HSP90α/β knockdown cells (Fig. 5h). Moreover, PP5 deletion delayed LATS inactivation by heat shock (Fig. 5i). These data suggest a model that HSP90 acts as a scaffold to facilitate the heat shock-induced LATS1 association with and dephosphorylation by PP5 (Fig. 5j). This model explains why heat shock is epistatic to many YAP inhibitory signals (Fig. 1) as these signals act upstream of MST1/2 and MAP4Ks.
YAP/TAZ enhance heat shock transcriptome and cell survival
Heat stress induces gene expression to provide adaptation and protection from harmful environment31. We deleted YAP/TAZ in mouse melanoma B16-OVA cells (Fig. 6a, Extended Data Fig. 4a). It is noteworthy that the YAP/TAZ knockout cells grow slower. YAP/TAZ deletion was functionally confirmed by the reduced expression of target genes CTGF and CYR61 (Extended Data Fig. 4b). We found that 43°C heat shock caused a small increase of cell death while 45°C caused more dramatic cell death, thus we used 45°C in the cell survival experiments. 45°C heat shock also induced YAP dephosphorylation (Fig. 6b). We compared cell viability of B16-OVA WT, YAP/TAZ DKO#2, and LATS1/2 DKO cells after 45°C heat shock for 1 hour. LATS1/2 DKO cells showed similar viability compared with WT cells; however, YAP/TAZ deletion significantly decreased viability from 80% to 45% (Fig. 6c). YAP/TAZ DKO#2 cells displayed more early apoptosis (Annexin V positive and 7-AAD negative) and late apoptosis/necrosis (double positive in Annexin V and 7-AAD), while no difference was found between WT and LATS1/2 DKO cells (Fig. 6d). Notably, basal apoptosis was slightly elevated by YAP/TAZ deletion. Trypan blue staining also confirmed more death of YAP/TAZ DKO#2 cells (Fig. 6e, f). The above data indicate that YAP/TAZ activation plays an important protective role in cellular heat stress adaptation.
In response to heat stress, cells upregulate HSPs for cellular homeostasis and protection 31, 32. We measured the classic HSPs, HSP25, HSP70, and HSP90 and found that their induction by heat shock was compromised in YAP/TAZ DKO#2 cells (Fig. 6g, h). Even basal HSP90α was repressed by YAP/TAZ deletion (Fig. 6h). YAP/TAZ knockdown by siRNA in B16-OVA also diminished HSP gene induction and increased apoptosis/necrosis upon heat shock (Extended Data Fig. 5a-e). Moreover, YAP/TAZ knockdown in SCC7 squamous carcinoma cells or HCT116 colon cancer cells similarly increased sensitivity to heat shock (Extended Data Fig. 5f-i). Furthermore, we conducted chromatin immunoprecipitation (ChIP) assay and observed that YAP bound to the promoters of HSPA1A, HSPB1 and DNAJB1, and this YAP interaction with HSP promoters was stimulated by heat shock (Fig. 6i). Taken together, our observations support a model that YAP/TAZ protect cells from heat stress, by directly promoting HSP expression.
We next performed RNA-SEQ of control and YAP/TAZ knockdown B16-OVA cells. In control siRNA treated cells, heat shock lead to upregulation of 418 genes and downregulation of 307 genes (Fig. 7a). Among the upregulated genes, YAP/TAZ knockdown completely abolished the induction of 348 genes and partially diminished the induction of 48 genes (Fig. 7b). Only 22 of the 418 inducible genes were not affected by YAP/TAZ knockdown. These data demonstrate a previously unrecognized profound role of YAP/TAZ in heat shock response. Gene Ontology analysis revealed that the YAP/TAZ-dependent genes are involved in phosphorylation, hemopoiesis, angiogenesis, stress response, and apoptosis (Extended Data Fig. 6a). These genes are involved in cell growth and survival control, such as MAPK and PI3K-AKT pathways (Extended Data Fig. 6b). The altered gene expressions of representative HSPs were confirmed by the FPKM (Extended Data Fig. 6c, d). Our RNA-SEQ data show that YAP/TAZ are required for proper induction of the heat shock transcriptome.
YAP/TAZ knockdown sensitizes B16-OVA tumor to hyperthermia
We evaluated the effect of YAP/TAZ silencing on tumor growth in murine syngeneic models in response to hyperthermia. Tumors grown from subcutaneously injected B16-OVA were treated with local hyperthermia using a 43°C water bath for 30 min on day 3 after siYAP/TAZ injection (Fig. 7c). We harvested tumors on day 21 and found that YAP/TAZ knockdown modestly reduced tumor volume and weight. Local hyperthermia also slightly decreased tumor weights in control siRNA (siCon) group. However, tumor growth of the YAP/TAZ knockdown B16-OVA cells was markedly suppressed by local hyperthermia (Fig. 7d-f). YAP/TAZ siRNA indeed reduced YAP/TAZ expression (Fig. 7g). Immunohistochemical staining showed a strong increase of cleaved caspase-3, an apoptosis marker, in the YAP/TAZ siRNA plus hyperthermia treatment group, compared to the YAP/TAZ siRNA or hyperthermia alone group (Fig. 7h). Collectively, these results show that YAP/TAZ knockdown sensitizes B16-OVA tumor cells to hyperthermia treatment.
DISCUSSION
In this study, we discovered that YAP is strongly activated by heat shock in many cell types and conditions. Heat shock-induced YAP activation is rapid, sustained, and reversible. The heat shock effect on YAP is rather unique as it is dominant over all YAP inhibitory signals tested. Interestingly, heat shock does not appear to act through MST and MAP4Ks, but rather directly impinges upon LATS inactivation. This is likely achieved by the heat shock-promoted association of LATS with PP5. Moreover, HSP90 is required for the interaction of LATS and PP5 by heat shock. We propose that heat shock inactivates LATS by promoting its association with and dephosphorylation by PP5 in a manner dependent on HSP90 (Fig. 5j). Consistent with this model, deletion of PP5 or HSP90 compromised the dephosphorylation of both LATS and its downstream substrate YAP in response to heat shock. Our model also explains why heat shock is dominant over many other YAP inhibitory signals as heat shock acts at the level of LATS while most other signals act upstream of MST and MAP4Ks. However, we cannot exclude the possibility that PP5 may participate in YAP dephosphorylation. Moreover, besides LATS inactivation, heat shock may activate phosphatase to dephosphorylate YAP.
Intriguingly, although the kinase activity of MST1 or MAP4K4 was not altered by heat shock, their interaction with LATS was increased (Fig. 3e-g), suggesting that MST1/2, as well as MAP4K4/6/7, may still phosphorylate LATS1 during heat shock. We speculate that MST1/2 is the major kinase, but can be partly compensated by MAP4K4/6/7, for LATS phosphorylation during heat shock. This may explain the delayed recovery of YAP re-phosphorylation at 37°C and the faster dephosphorylation of YAP upon heat shock in MST1/2 DKO cells (Fig. 3a, b, d). The rescue experiment in MM8KO cells further validates this hypothesis (Fig. 3h and Extended Data Fig. 2c). We speculate that the above phenomenon could be a consequence of cellular adaptation caused by a dynamic equilibrium between LATS phosphorylation and dephosphorylation. Nevertheless, our observations suggest that MST and MAP4K4 kinases are not key mediators of LATS inactivation in response to heat shock.
Although LATS dephosphorylation by heat shock was severely compromised in the HSP90 knockout or knockdown cells (Fig. 4c, d), YAP dephosphorylation was delayed but still occurred. Moreover, PP5 knockout or knockdown delayed but did not completely abolish the dephosphorylation of LATS and YAP in response to heat shock. These data indicate that additional mechanisms contribute to heat shock-induced regulation of the Hippo pathway, thus future studies are warranted.
Heat shock inhibits LATS by two mechanisms, dephosphorylation and protein degradation, but these two mechanisms appear to operate independently and with different time courses. HSP90 knockout blocks both LATS dephosphorylation and degradation, indicating the critical role of HSP90. Several E3 have been implicated in the LATS ubiquitination, including ITCH and SIAH233-35. We have made serious efforts to address the LATS E3 ubiquitin ligases. Knockdown ITCH or SIAH2 alone or in combination did not block the heat shock-induced LATS1 reduction (Extended Data Fig. 7). However, when both ITCH and SIAH2 were knocked down, basal LATS1 protein level was elevated (Extended Data Fig. 7). Further studies are needed to reveal the mechanism of LATS ubiquitination induced by heat stress.
A trivial explanation of our findings is that LATS inactivation is a nonspecific consequence of HSP limitation under heat shock if HSP is simply required for kinase folding and stability. However, our data strongly argue against this “nonspecific” model for the following reasons. First, LATS dephosphorylation occurs prior to the reduction of LATS proteins. Inhibition of LATS degradation by MG132 does not prevent LATS inactivation by heat shock. Second, the LATS phosphorylation is rapidly reversible upon temperature switch. Third, HSP90 knockout does not exacerbate LATS dephosphorylation or degradation as would be predicted by the “nonspecific” model. In contrast, HSP90 knockout suppresses LATS dephosphorylation and degradation by heat shock. Consistently, deletion of HSF-1, which is critically important for HSPs induction, has no effect on LATS regulation. Furthermore, we examined phosphorylation of many proteins, including numerous kinases, and found that heat shock did not cause a universal protein dephosphorylation and degradation (Extended Data Fig. 8). Collectively, our study shows that the Hippo pathway is actively regulated by heat shock.
Heat shock response is a ubiquitous and highly conserved protection mechanism 31. An immediate and prominent heat shock response is the rapid induction of genes, including HSP36. The fact that heat shock always activates YAP regardless of cell types or culture conditions suggests that YAP has important physiological roles in heat stress response. Notably, the C. elegans YAP-1 has been reported to be involved in thermotolerance37. Here, we show that YAP/TAZ are required for proper induction of the heat shock transcriptome, including many HSPs. 95% of heat inducible genes is blocked (83% completely and 12% partially) by YAP/TAZ deletion in the B16-OVA melanoma cells, suggesting a previously unrecognized and surprisingly prominent role of YAP/TAZ in the expression of heat inducible transcriptome. It should be noted that activation of YAP by LATS1/2 deletion was not sufficient to induce HSP expression while deletion of HSF-1 completely abolished the induction of HSPs (Fig. 6g and Extended Data Fig. 3a). We have analyzed ENCORE data (https://genome.ucsc.edu/cgi-bin/hgTrackUi?db=hg19&g=wgEncodeRegTfbsClusteredV3) for 45 heat inducible genes that are dependent on YAP/TAZ based on our RNA-SEQ data. Interestingly, genomic co-occupancy of TEAD4 and HSF-1 is found in the enhancers/promoters of more than 75% of these genes (Supplementary Table 1). These observations suggest that YAP/TAZ cooperate with HSF-1 to induce the heat shock transcriptome at least in B16 melanoma cells. Future studies to determine YAP regulation by heat shock under more physiological conditions, such as in heart and skin keratinocytes, will broaden the biological significance of our findings.
Consistent with their role in heat shock gene induction, silencing YAP/TAZ in B16-OVA cells increases apoptosis and suppresses tumor growth upon hyperthermia treatment. This study reveals an important interplay between YAP and cellular heat shock response, and suggests a possibility that targeting the Hippo pathway may enhance clinical effectiveness of hyperthermia therapy in cancer.
METHODS
Cell culture, transfection and heat shock
All the cell lines were cultured at 37°C with humidified 5% CO2. HEK293A, A549 and NIH3T3 were cultured in DMEM (Gibco) and A549, HCT116, B16-OVA and SCC7 were cultured in RPMI 1640 (Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco) and 50 μg/ml penicillin/streptomycin (Gibco). The cell lines were tested to be free of mycoplasma contamination. YAP-inhibitory signals and environmental stresses included the following: high cell density (100% confluence), serum starvation (2 h), glucose starvation (2-DG, 25 mM, 1 h), PKA activation (forskolin/IBMX, 10 μM/100 μM, 1 h), disruption of F-actin (latrunculin B, 0.25 μg/ml, 1 h), inhibition of actin polymerization (Cytochalasin D, 0.5 μM, 1 h), sorbitol (0.5 M, 0.5 h), and cell detachment (1 h).
PolyJet Reagent (SignaGen Laboratories) was used for all the in vitro plasmid DNA transfection according to the manufacturer’s protocol. For all the in vitro heat shock experiments, cells were seeded in 6 well plates (2 ml medium/well) and heat shocked in a culture incubator (Thermo Scientific) with humidified 5% CO2. The temperature of the incubator was set at least one day before the heat shock experiment and was always monitored by a mercurial thermometer. A tray filled with water was always be placed in the incubator to provide a relatively high humidity which favors efficient heat shock.
Antibodies
The following antibodies were purchased from Cell Signaling and used at the indicated dilution for western blot analysis and immunohistochemistry: YAP (D8H1X) (14074, 1:1,000), LATS1 (C66B5) (3477, 1:2,000), LATS2 (D83D6) (5888, 1:1,000), pLTAS1(T1079) (D57D3) (8654, 1:1,000), pYAP (S127) (4911, 1:1,000), MST1 (3682, 1:2,000), MST2 (3952, 1:2,000), pMST1 (T183) (E7U1D) (49332, 1:500), HSF-1 (D3L8I) (12972, 1:2,000), Ubiquitin (P4D1) (3936, 1:2,000), PP5 (2289, 1:2,000), MOB1 (E1N9D) (13730, 1:1,000), pMOB1(T35) (D2F10) (8699, 1:1,000), pAKT (D9E) (S473) (4060, 1:4,000), pSRC (Y416) (2101, 1:1,000), p70 S6 Kinase (49D7) (2708, 1:4,000), p-p70 S6 Kinase (T389) (108D2) (9234, 1:1,000), Erk1/2 (137F5) (4695, 1:4,000), pErk1/2 (T202/Y204) (D13.14.4E) (4370, 1:4,000), cleaved caspase 3 (9661, 1:1,000), HA (C29F4) (3724, 1:2,000) , HA-HRP (6E2) (2999, 1:5,000) and Myc-HRP (9B11) (2040, 1:5,000). The following antibodies were purchased from Santa Cruz Biotechnology and used at the indicated dilution for western blot analysis: YAP/TAZ (63.7) (sc-101199, 1:1,000), GAPDH (sc-25778, 1:4,000) and HSP90β (sc-7947, 1:4,000). FLAG (M2) (F1804, 1:2,000), FLAG-HRP (M2) (A8592, 1:5,000) and GST (2H3-D10) (SAB4200237, 1:4,000) were purchased from Sigma, MAP4K4 (A301-502A, 1:2,000) and MAP4K7 (A310-985A, 1:1,000) were purchased from Bethyl Laboratories, HSP90α (610418, 1:2,000) was purchased from BD Biosciences, HSP70 (10995-1-AP, 1:4,000), ITCH (20920-1-AP, 1:2,000), SIAH2 (12651-1-AP, 1:2,000) and AKT (10176-2-AP, 1:4,000) was purchased from Proteintech, SRC (JF0947) (ET1702-03, 1:5,000) was purchased from HuaAn Biotechnology Co., Ltd and HSP25 (ADI-SPA-801-D, 1:4,000) was purchased from Enzo Life Sciences. Alexa Fluor 488 secondary antibodies (A-11001, 1:1000) was purchased from Life Technologies.
CRISPR-mediated gene deletion
CRISPR genomic editing technology was used to delete genes in HEK293A and B16-OVA cells. The guide RNA sequences were cloned into the px459 plasmid (Addgene 48319). The constructed plasmids were transfected into HEK293A or B16-OVA using PolyJet. 24 h after transfection, the transfected cells were enriched by 2 μg/ml puromycin selection for 2–3 days and then were sorted into 96-well plates with only one cell in each well by FACS (UCSD; Human Embryonic Stem Cell Core, BDInflux). The clones were screened by western blot analysis with gene-specific antibodies. B16-OVA/LATS1/2 DKO, HEK293A/MST1/2 DKO and MAP4K4/6/7 TKO cells were generated as previously described38,39.
The single-guide RNA (sgRNA) sequences targeting individual genes were as follows:
human HSF-1#1: 5’-CAGCTTCCACGTGTTCGACC-3’;
human PP5#1: 5’-CGCGCTGCGAGACTACGAGA-3’;
human PP5#2: 5’-ACGCGCTGGGAGACGCCACG-3’;
human HSPA1A#2: 5’-AACCGGCATGGCCAAAGCCG-3’;
human HSPA1A#3: 5’-GGTGCTGGACAAGTGTCAAG-3’;
human HSPA1B#2: 5’-CACCGGCATGGCCAAAGCCG-3’;
human HSPA1B#3: 5’-GGTTCTGGACAAGTGTCAAG-3’;
human HSP90AA1#3: 5’-TTCTCTTGCAGGTGAACCTA-3’;
human HSP90AB1#3: 5’-CATTGCTATTTATTCCTCGT-3’;
mouse YAP1#2: 5’-GCCCAAGTCCCACTCGCGAC-3’,
mouse WWTR1#2: 5’-GCAGTGTCCCAGCCGAATCT-3’.
In vitro RNA interference
Duplex siRNAs targeting human HSP90AA1, HSP90AB1, or PP5 were purchased from Integrated DNA Technologies, Inc. (Skokie, USA) and siRNAs targeting human ITCH or SIAH2, mouse YAP1 and WWTR1 were purchased from GenePharma (Shanghai, China). siRNAs were transfected into cells in vitro with Lipofectamine® RNAiMAX (Invitrogen) in accordance with the manufacturer’s instructions.
The sequences are as follows:
siCon: UUCUCCGAACGUGUCACGUTT;
human siHSP90AA1#1: GCAUGGAAGAAGUAGACUAAUCUCT;
human siHSP90AA1#2: UUGACAAUUCUGCAUGUACUAGUCC;
human siHSP90AB1#1: GGACAGUGGUAAAGAGCUGAAAATT;
human siHSP90AB1#2: AGGCAGUAAACUAAGGGUGUCAAGC;
human siPP5#1: GUGACAAUCAGUUUCAUGAAGGAGC;
mouse siYAP1#1: GGUCAAAGAUACUUCUUAATT;
mouse siYAP1#2: CCAAUAGUUCCGAUCCCUUTT;
mouse siWWTR1#1: CCAGGAAGGUGAUGAAUCATT;
mouse siWWTR1#2: GCCGAAUCUCGCAAUGAAUTT.
human siYAP1#1: GGUCAGAGAUACUUCUUAATT;
human siYAP1#2: CCGUUUCCCAGACUACCUUTT.
human siWWTR1#1: CCUGCCGGAGUCUUUCUUUTT;
human siWWTR1#2: GGUACUUCCUCAAUCACAUTT.
human siITCH#2: CGGGCGAGUUUACUAUGUATT.
human siSIAH2#2: GUUCGAUUCAUGACGGUGUTT.
Western blot and immunoprecipitation.
Immunoblotting was performed using a standard protocol. The phos-tag reagents were purchased from Wako Chemicals, and gels containing phos-tag were prepared following the manufacturer’s instructions. For immunoprecipitation, HEK293A cells were lysed with mild lysis buffer (MLB, 50 mM Tris at pH7.5, 150 mM NaCl, 0.5% Triton-100, protease & phosphatase inhibitor cocktail) and centrifuged at 13, 000 rpm for 20 min at 4°C. Then supernatants were incubated with the appropriate antibodies with rotation overnight at 4°C and 10 μl Pierce Protein A/G Magnetic Beads (Thermo Scientific) were added in for additional 2 h. Immunoprecipitates were washed three times with mild lysis buffer, and then immunoprecipitated proteins were denatured by the addition of sample buffer and boiling for 10 min, resolved by 8% SDS–PAGE, and analyzed via western blot analysis.
In vivo LATS1 ubiquitination detection
HEK293A cells were transiently transfected with plasmids expressing HA-ubiquitin and FLAG-LATS1. 36 h after transfection, cells were treated with 10 μM MG132 (Millipore, 474790) for 6 h before harvesting. Cells were lysed in 200 μl of RIPA buffer (0.5% SDS), boiled at 95°C for 5 min, diluted with MLB to make final 0.1% SDS, then sonicated and centrifuged at 4°C (13, 000 rpm for 10 min). The supernatant was incubated with specific antibody at 4°C with rotation for 6 h and then 10 ul Pierce Protein A/G Magnetic Beads (Thermo Scientific) for another 2 h at 4°C. After washing, immunoprecipitated proteins were eluted with sample buffer, boiling for 10 min and subjected to IB analysis with anti-HA antibody to detect ubiquitylation.
RNA isolation and real-time PCR.
Cells were harvested for RNA extraction using the RNeasy Plus mini kit (Qiagen). 1 μg RNA was used for reverse transcription with iScript reverse transcriptase (Bio-Rad). cDNA was then used for real-time PCR with gene-specific primers using KAPA SYBR FAST qPCR master mix (Kapa Biosystems) and the CFX Connect real-time PCR system (Bio-Rad). Since the expression of some housekeeping genes might be affected by heat shock, we confirmed that 18S rRNA could be used as reference genes in our experiments. Relative mRNA abundance of the target gene was calculated using the ΔΔCt method normalized to the expression of 18S rRNA.
The primers (forward and reverse, respectively) used were as follows:
human CTGF, 5’-CCAATGACAACGCCTCCTG-3’ and 5’-TGGTGCAGCCAGAAAGCTC-3’;
human CYR61, 5’-AGCCTCGCATCCTATACAACC-3’ and 5’-TTCTTTCACAAGGCGGCACTC-3’;
human HSPA1A, 5’-AGAGCGGAGCCGACAGAG-3’ and 5’-CACCTTGCCGTGTTGGAA-3’;
human HSP90AA1, 5’-AGGAGGTTGAGACGTTCGC-3’ and 5’-AGAGTTCGATCTTGTTTGTTCGG-3’;
human HSPA6, 5’-GATGTGTCGGTTCTCTCCATTG-3’ and 5’-CTTCCATGAAGTGGTTCACGA-3’;
human DNAJB1, 5’-CTCTGGACGGCAGGACGATA-3’ and 5’-TCTTGATGTCTGGGGAATCCTT-3’;
human PP5, 5’-AAGACTCAGGCCAATGACTACT-3’ and 5’-CGCGTAGCCATAGCACTCAG-3’;
human ITCH, 5’-CTCTCTGCCGCCGACAAATA-3’ and 5’-TGGCAAGGGAGCTTGAGTTAC-3’;
human SIAH2, 5’-CGCCAGAAGTTGAGCTGCT-3’ and 5’-TGGTGGCATACTTACAGGGAA-3’;
mouse CTGF, 5’-AGCTGACCTGGAGGAAAACA-3’ and 5’-GACAGGCTTGGCGATTTTAG-3’;
mouse CYR61, 5’-GCTCAGTCAGAAGGCAGACC-3’ and 5’-GTTCTTGGGGACACAGAGGA-3’;
mouse HSPA1A, 5’-TGGTGCAGTCCGACATGAAG-3’ and 5’-GCTGAGAGTCGTTGAAGTAGGC-3’;
mouse HSP90AA1, 5’-TGTTGCGGTACTACACATCTGC-3’ and 5’-GTCCTTGGTCTCACCTGTGATA-3’;
mouse HSPB1, 5’-GGCAGGACGAACATGGCTACA-3’ and 5’-TCGAAAGTAACCGGAATGGTGAT-3’;
mouse YAP1, 5’-TACTGATGCAGGTACTGCGG-3’ and 5’-TCAGGGATCTCAAAGGAGGAC-3’;
mouse WWTR1, 5’-GAAGGTGATGAATCAGCCTCTG-3’ and 5’-GTTCTGAGTCGGGTGGTTCTG-3’;
18S rRNA, 5’-CGCCGCTAGAGGTGAAATTCT-3’ and 5’-CGAACCTCCGACTTTCGTTCT-3’.
Annexin V apoptosis detection
B16-OVA and SCC7 cells were heat shocked at 45°C for 1 h and collected after recovery at 37°C for 24 h for the detection of apoptosis. The PE Annexin V Apoptosis Detection Kit I (BD Pharmingen™) was used following the manufacturer protocol. Samples were then processed by the NovoCyte Flow Cytometer (ACEA Biosciences, Inc.), and the results were analyzed with FlowJo V10 software. Representative gating strategy and quantitative data for flow cytometry were provided in Supplementary Figure 1.
Cell viability detection
B16-OVA and SCC7 cells were heat shocked at the indicated temperature for 1 h and collected after recovery at 37°C for 24 h for the detection of cell viability. The Cell Counting Kit-8 (MedChemExpress) was used according to the manufacturer protocol. 100 μl of CCK8 were added in per 2 ml medium and cultured for additional 1.5 h, the absorbance at 450 nm was measured by Gen5™ Microplate Reader (BioTek Instruments) using area scanning method (3×3 points for 6 well plate). For the trypan blue exclusion experiments, appropriate trypan blue was added into the cells collected by trypsinization and the stain picture and quantification were performed by the automated cell counter (Countstar, China).
In vitro kinase assay
To analyze kinase activity, HEK293A cells with or without heat shock were collected and lysed with mild lysis buffer (50 mM Tris at pH7.5, 150 mM NaCl, 0.5% Triton-100, protease & phosphatase inhibitor cocktail) and immunoprecipitated with the indicated antibodies. The immunoprecipitates were washed three times with mild lysis buffer, followed by a single wash with TBS. Immunoprecipitated kinases were subjected to kinase assay in the 1× protein kinases buffer (BioLabs) in the presence of 0.5 mM ATP and 500 ng GST-YAP or GST-LATS2. The reaction mixtures were incubated at 30°C for 30 min with a shaker at 250 rpm. The reactions were then terminated with SDS sample buffer and subjected to SDS–PAGE. Phosphorylation of YAP and LATS was determined by phospho-YAP (Ser127) antibody and phospho-LATS (Thr1079) antibody respectively.
Immunofluorescence staining.
HEK293A and A549 cells were seeded on poly-L-ornithine (Sigma)-coated coverslips to the high density in 12 well plates. After heat shock at 43°C for the indicated time, cells were successively fixed in 4% paraformaldehyde and permeabilized with 0.2% Triton X-100 in PBS for 10 min at room temperature. Cells were blocked in PBS with 2% BSA and 2% goat serum for 30 min at room temperature and incubated overnight at 4°C in primary YAP/TAZ antibodies (Santa Cruz, 1:200) diluted in 1% BSA. After three washes with PBS, Alexa Fluor 488 secondary antibodies (Life Technologies, 1:1000) were diluted in 1% BSA and incubated for 1 h in the dark at room temperature. Slides were mounted with Prolong Gold antifade reagent with DAPI (Life Technologies). Images were captured with Olympus FV1000 confocal microscopy, immunofluorescence data were collected by NIS-Elements AR 5.11.00 imaging software and the signals from channels were merged by ImageJ (1.52a) software.
Immunohistochemistry.
Primary tumor paraffin sections were deparaffinized and rehydrated with xylene and alcohol gradients, and antigen retrieval was performed in citrate buffer (pH 6.0) followed by 3% H2O2 for 15 min to inhibit endogenous peroxidase activity. Sections were then incubated overnight at 4°C with cleaved-caspase 3 antibody and detected using SPlink Detection Kit and AEC Peroxidase Substrate kit (Zhongshan Golden Bridge Biotechnology Co., China) as per the manufacturer’s protocol.
RNA sequencing and bioinformatics analysis.
Total RNAs were extracted using TRIzol (Thermo Scientific) from siCon or siYAP/TAZ#2 treated B16-OVA cells with or without heat shock at 45°C for 1 h and recovered at 37°C for 6 h. Three replicates for each sample were generated and analysed. The resulting RNA was then used to prepare libraries using NEBNext® Ultra™ RNA Library Prep Kit for Illumina® (#E7530L, NEB, USA). The clustering of the index-coded samples was performed on a cBot cluster generation system using HiSeq PE Cluster Kit v4-cBot-HS (Illumina) and the libraries were sequenced on an Illumina platform and 150 bp paired-end reads were generated. Reads were aligned to the mm10 (Mus_musculus) reference genome. R was used to identify differentially expressed genes (DEGs). Genes with FPKM > 1, adjusted P value < 0.05 and Log2 Fold > 1 or < −1 were differentially expressed. GO and KEGG enrichment analysis of DEGs was performed also using R.
Chromatin immunoprecipitation (ChIP)
ChIP assay was performed using the SimpleChIP Enzymatic Chromatin IP Kit (Cell Signaling Technology, Cat. #9003), according to the manufacturer's instructions. Briefly, HCT116 cells were cross-linked, lysed, and digested to generate DNA fragments. A total of 50 μg of digested chromatin was incubated overnight with 2 μg of YAP antibody or control IgG. Precipitated DNA was quantitated by real-time PCR analysis.
The primers (forward and reverse, respectively) used were as follows:
human HSPA1A, 5’-TGGAGAGTTCTGAGCAGGGG-3’ and 5’-GCCTTTTCCCTTCTGAGCCA-3’;
human HSPB1, 5’-CCAGCGCCCCGCACTTTTCT-3’ and 5’-AGTCGCGGAAGGGGTCCCAG-3’;
human DNAJB1, 5’-GGCAGGAGGATGGTCTTCTT-3’ and 5’-TTAGTGGTGGGCTCTTCAGC-3’;
human CTGF, 5’-CTTTGGAGAGTTTCAAGAGCC-3’ and 5’-TCTGTCCACTGACATACATCC-3’
ChIP-seq analysis and Motif discovery
The available ChIP-seq data for transcription factors TEAD4 and HSF-1indicating genome-wide chromatin occupancy were obtained from ENCODE at UCSC Genome Browser (http://www.genome.ucsc.edu/ENCODE/), and the consensus sequence of known motifs were downloaded from Homer Motif database. (http://homer.ucsd.edu/homer/motif/HomerMotifDB/homerResults.html)
Animal work
Female BALB/c nude mice were purchased from Jiangsu GemPharmatech Co., Ltd (China). For syngeneic tumor models, B16-OVA cells (5 x 105) were injected subcutaneously into the left foot of 6-8-week-old female BALB/c nude mice. Mice were maintained in a specific pathogen-free facility (temperature 20°C-26°C, humidity 55%-65%, dark/light cycle12h/12h). Eight mice were assigned to each group. GP-siRNA-Mate Plus (MP) purchased from GenePharma (Shanghai, China) was used for the in vivo siRNA transfection in accordance with the manufacturer’s instructions. MP/siRNA complex (10 μg siRNA/50 μl total volume/mouse) were administered via intratumoral injection twice weekly beginning after the volume of the tumor reached around 30 mm3. Hyperthermia was given three days after siRNA treatment by immersing the tumor-bearing foot of mice in the 43°C water bath for 30 min. For subcutaneous tumor growth, the maximum single tumor cannot exceed 1.5 cm in diameter in mice according to the guidelines provided by the animal care program and no experiments in this study generated tumor burden over this limit. The mice were sacrificed 21 days after tumor inoculation, and tumors were harvested, weighed and fixed in 4% paraformaldehyde for immunohistochemistry. All animal experiments were performed as protocols approved by the Institutional Animal Care and Use Committee at Sichuan University.
Statistics and Reproducibility
All the experiments (including western blots) were independently repeated at least twice with similar results. Data are presented as mean ± s.d. or mean ± s.e.m as mentioned in each figure legend. P values were determined using two-sided unpaired t-test or one/two-way ANOVA test by GraphPad Prism 7 software (GraphPad Prism, San Diego, CA). The P values were considered statistically significant when p < 0.05.
Data Availability
The RNA sequencing data are available in GEO Data Sets with the accession number GSE133251. The available ChIP-seq data were obtained from ENCODE at UCSC Genome Browser (http://www.genome.ucsc.edu/ENCODE/) (UCSC accession number: wgEncodeEH002333, wgEncodeEH002345 and wgEncodeEH000754), and the consensus sequence of known motifs were downloaded from Homer Motif database (http://homer.ucsd.edu/homer/motif/HomerMotifDB/homerResults.html). Source data are provided with this paper. All other data that support the findings of this study are available on request from the corresponding author.
Extended Data
Supplementary Material
ACKNOWLEDGMENTS
This work was supported by grants from the National Institutes of Health (CA196878 and DE015694) to K.L.G. This study was supported by grants from National Natural Science Foundation of China (31800773), China Postdoctoral Science Foundation (2018M633369), Sichuan Science and Technology Program (2019YJ0063), The Youth Science Foundation of West China Hospital of Stomatology (WCHS-201703) to M.L. This work was supported by the National Major Scientific and Technological Special Project for “Significant New Drugs Development” (No. 2018ZX09733001, China), the Development Program of China (No. 2016YFA0201402), and by the Excellent Youth Foundation of Sichuan Scientific Committee Grant in China (No. 2019JDJQ008) to X.W.W. This research was also partly funded by the China Scholarship Council (CSC NO. 201506240035).
We thank Faxing Yu from Fudan University and Bin Zhao from Zhejiang University for reagents.
Footnotes
COMPETING FINANCIAL INTERESTS
K.-L.G. is a co-founder and has an equity interest in Vivace Therapeutics, Inc. The other authors declare no competing interests.
References
- 1.Yu F-X, Zhao B & Guan K-L Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163, 811–828 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Pan D The hippo signaling pathway in development and cancer. Developmental cell 19, 491–505 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lin KC, Park HW & Guan K-L Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer. Annual Review of Cancer Biology 2, 59–79 (2018). [Google Scholar]
- 4.Harvey KF, Zhang X & Thomas DM The Hippo pathway and human cancer. Nature Reviews Cancer 13, 246 (2013). [DOI] [PubMed] [Google Scholar]
- 5.Meng Z, Moroishi T & Guan K-L Mechanisms of Hippo pathway regulation. Genes & development 30, 1–17 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dong J et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120–1133 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zhao B et al. TEAD mediates YAP-dependent gene induction and growth control. Genes & development 22, 000–000 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Åkerfelt M, Morimoto RI & Sistonen L Heat shock factors: integrators of cell stress, development and lifespan. Nature reviews Molecular cell biology 11, 545 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wust P et al. Hyperthermia in combined treatment of cancer. The lancet oncology 3, 487–497 (2002). [DOI] [PubMed] [Google Scholar]
- 10.Roti Roti JL Cellular responses to hyperthermia (40–46 C): Cell killing and molecular events. International Journal of hyperthermia 24, 3–15 (2008). [DOI] [PubMed] [Google Scholar]
- 11.Zhang H-G, Mehta K, Cohen P & Guha C Hyperthermia on immune regulation: a temperature’s story. Cancer letters 271, 191–204 (2008). [DOI] [PubMed] [Google Scholar]
- 12.Hansen CG, Moroishi T & Guan KL YAP and TAZ: a nexus for Hippo signaling and beyond. Trends Cell Biol 25, 499–513 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Zhao B et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes & Development 21, 2747–2761 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Budzyński MA, Puustinen MC, Joutsen J & Sistonen L Uncoupling Stress-Inducible Phosphorylation of Heat Shock Factor 1 from Its Activation. Molecular and Cellular Biology 35, 2530–2540 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Chan EH et al. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24, 2076–2086 (2005). [DOI] [PubMed] [Google Scholar]
- 16.Hergovich A, Schmitz D & Hemmings BA The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. Biochem Bioph Res Co 345, 50–58 (2006). [DOI] [PubMed] [Google Scholar]
- 17.Ni L, Zheng Y, Hara M, Pan D & Luo X Structural basis for Mob1-dependent activation of the core Mst-Lats kinase cascade in Hippo signaling. Genes Dev 29, 1416–1431 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wang W et al. AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nature Cell Biology 17, 490–499 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Mo J-S et al. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nature cell biology 17, 500–510 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Hong AW et al. Osmotic stress-induced phosphorylation by NLK at Ser128 activates YAP. EMBO reports 18, 72–86 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Trinklein ND, Murray JI, Hartman SJ, Botstein D & Myers RM The role of heat shock transcription factor 1 in the genome-wide regulation of the mammalian heat shock response. Mol Biol Cell 15, 1254–1261 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Huntoon CJ et al. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway. Cancer research 70, 8642–8650 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Raghunathan VK et al. Involvement of YAP, TAZ and HSP90 in contact guidance and intercellular junction formation in corneal epithelial cells. PloS one 9, e109811 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Ran FA et al. Genome engineering using the CRISPR-Cas9 system. Nature protocols 8, 2281 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Papp E & Csermely P Chemical Chaperones: Mechanisms of Action and Potential Use, in Molecular Chaperones in Health and Disease. (eds. Starke K & Gaestel M) 405–416 (Springer Berlin Heidelberg, Berlin, Heidelberg; 2006). [DOI] [PubMed] [Google Scholar]
- 26.Sreedhar AS, Kalmár É, Csermely P & Shen Y-F Hsp90 isoforms: functions, expression and clinical importance. FEBS letters 562, 11–15 (2004). [DOI] [PubMed] [Google Scholar]
- 27.Russell LC, Whitt SR, Chen M-S & Chinkers M Identification of conserved residues required for the binding of a tetratricopeptide repeat domain to heat shock protein 90. Journal of Biological Chemistry 274, 20060–20063 (1999). [DOI] [PubMed] [Google Scholar]
- 28.Das AK, Cohen PT & Barford D The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR-mediated protein–protein interactions. The EMBO journal 17, 1192–1199 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Yu F-X et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780–791 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Chen R, Xie R, Meng Z, Ma S & Guan KL STRIPAK integrates upstream signals to initiate the Hippo kinase cascade. Nat Cell Biol 21, 1565–1577 (2019). [DOI] [PubMed] [Google Scholar]
- 31.Jolly C & Morimoto RI Role of the heat shock response and molecular chaperones in oncogenesis and cell death. Journal of the National Cancer Institute 92, 1564–1572 (2000). [DOI] [PubMed] [Google Scholar]
- 32.Kregel KC Invited review: heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance. Journal of applied physiology 92, 2177–2186 (2002). [DOI] [PubMed] [Google Scholar]
- 33.Ma B et al. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. Nature cell biology 17, 95 (2015). [DOI] [PubMed] [Google Scholar]
- 34.Salah Z, Melino G & Aqeilan RI Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity. Cancer research 71, 2010–2020 (2011). [DOI] [PubMed] [Google Scholar]
- 35.Ho KC et al. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability. Proceedings of the National Academy of Sciences 108, 4870–4875 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Richter K, Haslbeck M & Buchner J The heat shock response: life on the verge of death. Mol Cell 40, 253–266 (2010). [DOI] [PubMed] [Google Scholar]
- 37.Iwasa H et al. Yes-associated protein homolog, YAP-1, is involved in the thermotolerance and aging in the nematode Caenorhabditis elegans. Experimental cell research 319, 931–945 (2013). [DOI] [PubMed] [Google Scholar]
- 38.Meng Z et al. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat Commun 6, 8357 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Moroishi T et al. The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity. Cell 167, 1525–1539 e1517 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The RNA sequencing data are available in GEO Data Sets with the accession number GSE133251. The available ChIP-seq data were obtained from ENCODE at UCSC Genome Browser (http://www.genome.ucsc.edu/ENCODE/) (UCSC accession number: wgEncodeEH002333, wgEncodeEH002345 and wgEncodeEH000754), and the consensus sequence of known motifs were downloaded from Homer Motif database (http://homer.ucsd.edu/homer/motif/HomerMotifDB/homerResults.html). Source data are provided with this paper. All other data that support the findings of this study are available on request from the corresponding author.